Effectiveness of recombinant erythropoietin and iron sucrose vs. iron therapy only, in patients with postpartum anaemia and blunted erythropoiesis

European Journal of Clinical Investigation

Volumn 30, Issue 2, 2000, Pages 154-161

  Breymann, Christian ^a   Richter, C ^b   Huttner C ^b   Huch, R ^b   Huch, A ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b NONE

Author keywords

Blunted erythropoiesis; Caesarean section; Intravenous iron; Postpartum anaemia; Recombinant erythropoietin

Indexed keywords

C REACTIVE PROTEIN; FERRIC HYDROXIDE SUCROSE; FERRITIN; FERROUS SULFATE; GYNOTARDIFERON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN; UNCLASSIFIED DRUG;

ANEMIA; ARTICLE; CESAREAN SECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EPIGASTRIC PAIN; ERYTHROPOIESIS; FEMALE; FERRITIN BLOOD LEVEL; HEMATOCRIT; HUMAN; IRON BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; TASTE DISORDER; TRANSFERRIN BLOOD LEVEL;

ANEMIA; CESAREAN SECTION; DRUG ADMINISTRATION ROUTES; DRUG THERAPY, COMBINATION; ERYTHROCYTE COUNT; ERYTHROPOIESIS; ERYTHROPOIETIN; FEMALE; HUMANS; IRON; IRON, DIETARY; POSTPARTUM PERIOD; RETICULOCYTES; SUCROSE;

EID: 0033961976     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2000.00605.x     Document Type: Article

References (47)

1. 1 Gilbert L, Porter W, Brown VA. Postpartum haemorrhage-a continuing problem. Br J Obst Gynecol 1987;94:67-71.
2. 2 Combs CA, Murphy EL, Laros RK. Factors associated with postpartum hemorrhage with vaginal birth. Obstet Gynecol 1991;72:69-76.
3. 3 Morrison JC, Floyd RC, Martin JN, Dodson M, Roberts W, Morrison FG. Blood Transfusions after Postpartum Hemorrhage due to Uterine Atony. J Matern Fetal Invest 1991;1:209-12.
4. 4 Morrison JC, Morrison FG. Rational use of blood products in obstetrics and gynecology. J Matern Fetal Invest 1994;4:147-53.
5. 5 Gillon J, Greenburg AG. Transfusion: infectious complications, Coplications Surg 1992;11:19-28.
6. 6 Waymack JP, Yurt RW. The effect of blood transfusions on immune function. J Surg Res 1990;48:147-53.
7. 7 Crosby L, Palarski VA, Cottington E, Cmolik B. Iron supplementation for acute blood loss anemia after coronary bypass surgery: a randomised placebo-controlled study. Heart-Lung 1994;23:493-9.
8. 8 Skikne BS, Cook JD. Effect of enhanced erythropoiesis on iron absorption. J Lab Clin Med 1992;120:746-51.
9. 9 Schindler E, Scholz S, Boldt J, Zickmann B, Knothe C, Dietrich G et al. Effectiveness of oral versus parenteral iron substitution in autologous blood donors. Infusionsther-Transfusionsmed 1994;21:236-41.
10. 10 Erslev AJ. Anemia of chronic disease. In: Beutler E, Lichtman M, Coller B, Kipps T, editors. Williams Hematology New York:McGraw-Hill Inc.;1995.p.518-24.
11. 11 Cazzola M, Mercuriali F, Brugnara C. Use of recombinant human erythropoietin outside the setting of uremia. Blood 1997;89:4248-67.
12. 12 Goodnough LT, Price TH, Rudnick S. Iron-restricted erythropoiesis as a limitation to autologous blood donation in the erythropoietin-stimulated bone marrow. J Lab Clin Med 1991;118:289-96.
13. 13 Jacobs P, Finch CA. Iron for erythropoiesis. Blood 1971;37:220-30.
14. 14 Macdougall IC, Hutton RD, Cavill I, Coles GA, Williams JTJ. Poor response to treatment of renal anemia with erythropoietin corrected by iron given intravenously. Br Med J 1989;299:157-8.
15. 15 Danko J, Huch R, Huch A. Epoetin alfa for treatment of postpartum anaemia. Lancet 1990;I:737-8.
16. 16 Huch A, Eichhorn KH, Danko J, Lauener PA, Huch R. Recombinant Human Erythropoietin (rHuEPO) in the Treatment of Post Partum Anemia. Obstet Gynecol 1992;80:127-31.
17. 17 Vora M, Gruslin A. Erythropoietin in Obstetrics. Obstetr Gynecol Survey 1998;53:500-8.
18. 18 Spivak J. The clinical physiology of erythropoietin. Seminars Hematol 1993;30:2-11.
19. 19 Macdougall I, Cavill I, Hulme B, Bain B, McGregor E, McKay P. Detection of functional iron deficiency during erythropoietin treatment: a new approach. Br Med J 1992;304:225-6.
20. 20 Van Wyck DB. Iron management during recombinant erythropoietin therapy. Am J Kidney Dis 1989;14 (Suppl. 1):9-13.
21. 21 Zimmermann R, Breymann C, Huch R, Huch A. rHuEPO in the treatment of postpartum anemia: subcutaneous versus intravenous administration. Clin Invest 1994;72:S 25-S 30.
22. 22 Breymann C, Zimmermann R, Huch R, Huch A. Use of rhEPO in combination with parenteral iron for the treatment of postpartum anemia. European J Clin Invest 1996;23: 123-6.
23. 23 Tanke H, Rothbarth P, Vossen J, Koper G, Ploem J. Flow Cytometry of Reticulocytes Applied to Clinical Hematology. Blood 1983;61:1091-7.
24. 24 Tanke HJ, Nieuwenhuis I, Koper GJ, Slats J, Ploem JS. Flow Cytometry of Human Reticulocytes Based on RNA Fluorescence. Cytometry 1980;1:313-20.
25. 25 Major A, Bauer C, Breymann C, Huch R, Huch A. rh-Erythropoietin stimulates immature reticulocyte release in man. Br J Haematol 1994;87:605-8.
26. 26 Barosi G. Inadequate erythropoietin response to anemia. Definition and clinical relevance. Ann Hematol 1994;68:215.
27. 27 Levine EA, Rosen AL, Gould SA, Sehgal LR, Egrie JC, Browne J et al. Recombinant human erythropoietin and autologous blood donation. Surgery 1988;104:365-9.
28. 28 Levine EA, Gould SA, Rosen AL, Sehgal LR, Egrie JC, Sehgal HL, et al. Perioperative recombinant human erythropoietin. Surgery 1989;106:432-7.
29. 29 Koestner JA, Nelson LD, Morris JA, Safcsak K. Use of Recombinant Human Erythropoietin (r-HuEPO) in a Jehova's Witness Refusing Transfusion of Blood Products. Case Report J Trauma 1990;30:1406-8.
30. 30 Koenig HM, Levine EA, Resnick DJ, Meyer WJ. Use of Recombinant Human Erythropoietin in a Jehovah's Witness. J Clin Anesth 1993;5:244-7.
31. 31 Fullerton DA, Campbell DN, Whitman GJ. Use of Human Recombinant Erythropoietin to Correct Severe Preoperative Anemia. Ann Thorac Surg 1991;51:823-4.
32. 32 Bornmann, Bv Weiler J, Aulich S. Acute treatment with recombinant erythropoietin in patients with pre-and post-operative anemia: a clinical report. Clin Invest 1994; 72:S 31-S 35.
33. 33 Breymann C, Perewusnyk G, Guntermann H, Hänseler E, Huch R. Unrecognised iron deficiency in critical illness. Lancet 1999;353:841-2.
34. 34 Romem Y, Artal R. C-reactive protein in pregnancy and in the postpartum period. Am J Obstet Gynecol 1985;151:380-3.
35. 35 Biesma DH, van de Wiel A, Beguin Y, Kraaijenhagen JR, Marx JJ. Erythropoietic activity and iron metabolism in autologous blood donors during recombinant human erythropoietin therapy. Eur J Clin Invest 1994;24:426-32.
36. 36 Faquin WC, Schneider TJ, Goldberg MA. Effect of inflammatory cytokines on hypoxia induced erythropoietin production. Blood 1992;79:1987-94.
37. 37 Means RT, Krantz SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992;80:1639.
38. 38 Breymann C, Bauer C, Zimmermann R, Gautschi K, Major A, Huch R et al. Optimal timing of repeated erythropoietin administration improves its effectiveness in stimulating erythropoiesis in healthy volunteers. Br J Haematol 1996;92:295-301.
39. 39 Tsuda I, Tatsumi N. Maturity of Reticulocytes in Various Hematological Disorders. Eur J Haematol 1989;43:252-4.
40. 40 Danielson BG, Salmonson T, Derendorf H, Geisser P. Pharmakokinetics of iron (III) -hydroxide sucrose complex after a single intravenous dose in healthy volunteers. Arzneim Forsch Drug Res 1996;46:615-21.
41. 41 Henderson AP, Hillman RS. Characteristics of Iron Dextran Utilization in Man. Blood 1969;34:357-75.
42. 42 Hamstra RD, Block MH, Schocket AL. Intravenous Iron Dextran in Clinical Medicine. JAMA 1980;243:1726-31.
43. 43 Jacobs P. Clinical use of total-dose infusion of iron dextran. S Afr Med J 1985;67:837-8.
44. 44 Hoigne R, Breymann C, Künzi UP, Brunner F. Parenteral iron therapy: problems and possible solutions. Schweiz Med Wochenschr 1998;128:528-35.
45. 45 Meyer JW, Eichhorn KH, Vetter K, Christen S, Schleusner E, Klos A et al. Does rhEPO not only treat anemia but reduce postpartum distress as well. J Perinat Med 1995;23:99-109.
46. 46 Mamelle N, Gerin P, Measson A, Munoz F, Collet P. Assessment of psychological modifications during pregnancy: contribution of Derogatis Symptom Checklist (SCL-90-R). J Psychosom Obstet Gynecol 1987;7:39-45.
47. 47 Krafft A, Breymann C, Hüttner C, Huch R, Huch A. Erythropoietic quality of maternal milk. Lancet 1999;354: 778.